The pharma industry is still holding on to its COVID-19 halo in the eyes of patient advocacy groups, according to the latest PatientView survey on corporate reputatio...

After Novartis drafted plans to wed its pharma and oncology businesses earlier this month, reports of potential layoffs poured in. Now, as Novartis taps prolific Wall...

Even though most people in the U.S. have been eligible for COVID-19 vaccines and boosters for quite some time, children under 5 still don't have vaccine options. Now,...

As part a major reorganization, Novartis CEO Vas Narasimhan created a new position overseeing the company’s corporate strategy. Now, he has found that leader in the f...

Amcor, a global packaging giant, will upgrade its healthcare packaging facility in Sligo, Ireland, as it looks to support growth in the medical device arena. The ...

Cancer Research UK, the world's largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approach...

Johnson & Johnson never came up with a name for its COVID-19 vaccine. Similarly, it never found a niche for the jab, despite its hype as a convenient single-shot ...

Gilead Sciences’ Kite Pharma has further beefed up its cell therapy manufacturing footprint fresh on the heels of an FDA go-ahead for Yescarta as the first CAR-T ther...

Pfizer’s oral COVID-19 antiviral Paxlovid has hit an unexpected decline in worldwide demand, according to a new analysis from Reuters. After a clinical trial showed ...

Could the third time be the charm for an oral HIF-PH inhibitor in the U.S.? GlaxoSmithKline certainly hopes so, with its potential first-in-class medicine now officia...